 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Forvisirvat is the INN for a sirtuin activator (WHO INN proposed list 133, July 2025). It is one of the compounds claimed in Sirtsei Pharmaceuticals' patent WO2021202822A1 [2]. The structure was disclosed as the sirtuin 6 activator clinical candidate SP-624 in early 2025, with suggested potential in psychiatric, neurodegenerative and metabolic disorders [3].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| IUPAC Name  | 
| (2S,5'R)-7-chloro-3',4-dimethoxy-5'-methyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 13727 | forvisirvat | 
| Synonyms  | |
| Compound 1 [WO2024148149A2] [1] | DS-7830a [1] | SP-624 | SP624 | |
| Database Links  | |
| CAS Registry No. | 2135638-06-9 (source: WHO INN record) | 
| GtoPdb PubChem SID | 518520675 | 
| PubChem CID | 131964504 | 
| Search Google for chemical match using the InChIKey | MIHSWFYCAJWPIS-YLVJLNSGSA-N | 
| Search Google for chemicals with the same backbone | MIHSWFYCAJWPIS | 
| Search PubMed clinical trials | forvisirvat | 
| Search PubMed titles | forvisirvat | 
| Search PubMed titles/abstracts | forvisirvat | 
| UniChem Compound Search for chemical match using the InChIKey | MIHSWFYCAJWPIS-YLVJLNSGSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | MIHSWFYCAJWPIS-YLVJLNSGSA-N |